Trial Profile
Multi Center, Randomized, Double-blind, Placebo-controlled Parallel-group, Phase II Clinical Trial to Evaluate the Safety and Efficacy of PAC-14028 Cream in Mild to Moderate Atopic Dermatitis Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2019
Price :
$35
*
At a glance
- Drugs Asivatrep (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors AmorePacific
- 08 Jan 2019 Results assessing the safety and efficacy of PAC-14028 published in the British Journal of Dermatology.
- 08 Jan 2019 Primary endpoint has been met. (Success rate of Investigators Global Assessment (IGA))
- 10 Jan 2017 New trial record